논문KCI 등재
The Prognostic Value of Residual Nonrectal Inflammation in Ulcerative Colitis
2
조회
0
다운로드
0
인용
0
참고문헌
참고문헌 (10)
- Shin Jongbeom, "Clinical Significance of Residual Nonrectal Inflammation in Ulcerative Colitis Patients in Clinical Remission", Gut and Liver, 15(3), pp.401~409 (2021), 거트앤리버 소화기연관학회협의회[DOI]
- Toshifumi Hibi, "Predictive factors for achievement of mucosal healing by budesonide 2-mg foam in ulcerative colitis: a pooled analysis of data from two clinical trials", Intestinal research, 18(1), pp.56~68 (2020), 대한장연구학회
- Dulai PS, "Prevalence of endoscopic improvement and remission according to patient-reported outcomes in ulcerative colitis", Aliment Pharmacol Ther, 51, pp.435~445 (2020)
- Ishihara S, "irritable bowel syndrome-like symptoms in ulcerative colitis patients in clinical remission : association with residual colonic inflammation", Digestion, 99, pp.46~51 (2019)
- Fukuba N, "Prevalence of irritable bowel syndrome-like symptoms in ulcerative colitis patients with clinical and endoscopic evidence of remission : prospective multicenter study", Scand J Gastroenterol, 49, pp.674~680 (2014)
- Asonuma K, "Residual shortsegment distal inflammation has no significant impact on the major relapse of extensive ulcerative colitis", Inflamm Bowel Dis, 28, pp.200~207 (2022)
- Shinta Mizuno, "5-Aminosalicylic acid intolerance is associated with a risk of adverse clinical outcomes and dysbiosis in patients with ulcerative colitis", Intestinal research, 18(1), pp.69~78 (2020), 대한장연구학회
- Ajit Sood, "Colitis and Crohn’s Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease", Intestinal research, 18(4), pp.355~378 (2020), 대한장연구학회[DOI]
- Toshifumi Hibi, "Efficacy of biologic therapies for biologic-naïve Japanese patients with moderately to severely active ulcerative colitis: a network meta-analysis", Intestinal research, 19(1), pp.53~61 (2021), 대한장연구학회[DOI]
- Choon Jin Ooi, "Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn’s disease in Asia", Intestinal research, 17(3), pp.285~310 (2019), 대한장연구학회[DOI]
관련 논문AI추천
Clinical Significance of Residual Nonrectal Inflammation in Ulcerative Colitis Patients in Clinical Remission김영호, Chang Dong Kyung, Hong Sung Noh, Kim Eun Ran, Kim Tae Jun, Kong Sung Min, Shin Jongbeom거트앤리버 소화기연관학회협의회 · Gut and Liver2021 · 제15권 제3호The Clinical Significance and Risk Factors of Colorectal Stricture in Ulcerative ColitisSung Chul Park, Yoon Tae Jeen거트앤리버 소화기연관학회협의회 · Gut and Liver2020 · 제14권 제5호Fecal Immunochemical Test and Fecal Calprotectin Measurement Are Noninvasive Monitoring Tools for Predicting Endoscopic Activity in Patients with Ulcerative Colitis천재희, Ji Young Chang거트앤리버 소화기연관학회협의회 · Gut and Liver2018 · 제12권 제2호Is the Long-term Disease Course of Elderly-Onset Ulcerative Colitis Different from That of Non-Elderly-Onset Ulcerative Colitis?김은수, Lee Jin Wook거트앤리버 소화기연관학회협의회 · Gut and Liver2021 · 제15권 제5호Could histologic healing be a new treatment target in patients with ulcerative colitis?Sang Hyoung Park, Soyoung Kim대한내과학회 · The Korean Journal of Internal Medicine2024 · 제39권 제1호The Cumulative Colectomy Rate in Patients with Cytomegalovirus-Positive Ulcerative ColitisAhmet Uygun, Hakan Demirci, Kadir Ozturk, Murat Kantarcioglu, Sait Bagci거트앤리버 소화기연관학회협의회 · Gut and Liver2015 · 제9권 제2호
이 간행물의 다른 논문 (20건)
Ulcerative Colitis and Patient’s Quality of Life, Especially in Early Stage이정원pp. 317-318Waiting for Multi-Stakeholders’Consensus Position Statement on New Nonalcoholic Fatty Liver Disease NomenclatureYoon Eileen L., Jun Dae Wonpp. 319-320Advancements in the Diagnosis of Gastric Subepithelial TumorsKaise Mitsuru, Goto Osamu, Iwakiri Katsuhikopp. 321-330Postinfection Irritable Bowel SyndromeGhoshal Uday Cpp. 331-3402021 Korean Society of Gastrointestinal Endoscopy Clinical Practice Guidelines for Endoscopic SedationPark Dong-ah, 박홍준, Kim Byung-Wook, Park Jin Myung, Cho Joo Young, Seo Seung Young, Park Yehyun, Bae Jun Yong, Lee Jee Hyun, Chung Jun-Won, 최현호, Kim Myung Ha, 정재흥, 전형구, Lee Jun Kyu, Lee Jae Minpp. 341-356
